Mount Sinai Hospital, Canada
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mount Sinai Hospital, Canada sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Mount Sinai Hospital, Canada: 7 sponsored US clinical trials, 2 recruiting.
Mount Sinai Hospital, Canada sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Adult Soft Tissue Sarcoma, with 1 trials.
Upper-quartile sponsor footprint
Mount Sinai Hospital, Canada sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
NCT06004739
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
NCT05347238
Preoperative vs Postoperative IMRT for Extremity/Truncal STS
NCT02565498
Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)
NCT04153864
Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension
NCT04402645
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
NCT01788527
Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.
NCT00675363
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Therapeutic Areas
Where Mount Sinai Hospital, Canada enrollment is open (later-stage tilt)
2 recruiting of 7 indexed (29% open); 4 completed (57%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Adult Soft Tissue Sarcoma (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mount Sinai Hospital, Canada: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Mount Sinai Hospital, Canada sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
Related
What to do with this Mount Sinai Hospital, Canada page
7 registered trials is a research-attention snapshot, not an endorsement of Mount Sinai Hospital, Canada or any single study.
- 2 of Mount Sinai Hospital, Canada's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Adult Soft Tissue Sarcoma is the condition Mount Sinai Hospital, Canada studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Adult Soft Tissue Sarcoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mount Sinai Hospital, Canada pipeline card: 7 registered trials from official public datasets.Report a data error.